Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Iwama

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
International Journal of Oncology|July 31, 1998
Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromesH Nasu, N Hibi, J H Ohyashiki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 24, 1999
[Induction of Ph-negative normal clone and long-term survival by combined treatment with G-CSF plus middle dose cytosine arabinoside for patients with chronic myeloid leukemia in blastic transformation]T Katagiri, K Miyazawa, Y Uchida, et al.
Science (New York, N.Y.)|June 13, 1997
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1K Tanaka, K Watase, T Manabe, et al.
Leukemia|March 23, 1999
The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromesH Tamaki, H Ogawa, K Ohyashiki, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
International Journal of Oncology|July 31, 1998
Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromesH Nasu, N Hibi, J H Ohyashiki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 24, 1999
[Induction of Ph-negative normal clone and long-term survival by combined treatment with G-CSF plus middle dose cytosine arabinoside for patients with chronic myeloid leukemia in blastic transformation]T Katagiri, K Miyazawa, Y Uchida, et al.
Science (New York, N.Y.)|June 13, 1997
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1K Tanaka, K Watase, T Manabe, et al.
Leukemia|March 23, 1999
The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromesH Tamaki, H Ogawa, K Ohyashiki, et al.
Pageof 9